Literature DB >> 8696939

Interleukin-8 production by macrophages from atheromatous plaques.

J Apostolopoulos1, P Davenport, P G Tipping.   

Abstract

Interleukin-8 (IL-8) is a chemotactic peptide produced by macrophages that may be involved in the recruitment of inflammatory cells into atherosclerotic plaques. In vitro, IL-8 production by macrophages isolated from carotid plaques (1240 +/- 510 pg.10(5) cells-1.24h-1, mean +/- SEM, n = 6) and noncarotid plaques (4312 +/- 1588 pg.10(5) cells-1.24 h-1, n = 9) was significantly greater than IL-8 production by blood monocytes isolated from the same patients (526 +/- 278 pg.10(5) cells-1.24 h-1, n = 6, P < .05 and 726 +/- 384 pg.10(5) cells-1.24 h-1, n = 9, P < .01, respectively). IL-8 produced by atherosclerotic macrophages was demonstrated to be biologically active in a neutrophil chemotaxis assay. IL-8 mRNA was detectable in plaque macrophages and blood monocytes from these patients, but blood monocytes from normal donors did not exhibit detectable IL-8 mRNA. IL-8 mRNA was localized in macrophage-rich areas of atherosclerotic plaques by in situ hybridization. These studies demonstrate that macrophages from atherosclerotic plaques show an enhanced capacity to produce IL-8 compared with normal and patient blood monocytes and that macrophages are a major site of IL-8 mRNA production in atherosclerotic plaques. These results provide further evidence for a proinflammatory role for macrophages in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8696939     DOI: 10.1161/01.atv.16.8.1007

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  29 in total

Review 1.  Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias.

Authors:  Stavros Apostolakis; Virginia Amanatidou; Demetrios A Spandidos
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

2.  Genetic regulation of endothelial inflammatory responses in baboons.

Authors:  David L Rainwater; Qiang Shi; Michael C Mahaney; Vida Hodara; John L Vandeberg; Xing Li Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-27       Impact factor: 8.311

Review 3.  Interleukin-8 and its receptor CXCR2 in atherosclerosis.

Authors:  W A Boisvert; L K Curtiss; R A Terkeltaub
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

4.  Local perivascular adiponectin associates with lower extremity vascular operative wound complications.

Authors:  Gaurav Sharma; Rohan Kulkarni; Samir K Shah; William W King; Alban Longchamp; Ming Tao; Kui Ding; C Keith Ozaki
Journal:  Surgery       Date:  2016-04-14       Impact factor: 3.982

Review 5.  Erythrocyte Duffy antigen receptor for chemokines (DARC): diagnostic and therapeutic implications in atherosclerotic cardiovascular disease.

Authors:  Stavros Apostolakis; Georgios K Chalikias; Dimitrios N Tziakas; Stavros Konstantinides
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

6.  Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis.

Authors:  A Desai; H A Lankford; J S Warren
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

7.  Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression.

Authors:  William A Boisvert; David M Rose; Kristen A Johnson; Maria E Fuentes; Sergio A Lira; Linda K Curtiss; Robert A Terkeltaub
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 8.  Regulation of atherogenesis by chemokines and chemokine receptors.

Authors:  Wuzhou Wan; Philip M Murphy
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2012-12-07       Impact factor: 4.291

9.  ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis.

Authors:  M A Hernández-Presa; C Bustos; M Ortego; J Tuñón; L Ortega; J Egido
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.

Authors:  Y Koizumi; T Kurita-Ochiai; S Oguchi; M Yamamoto
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.